# Pharmacokinetic/Pharmacodynamic Drug-drug Interaction of LC15-0444 and Metformin After Oral Administration in Healthy Male Subjects

> **NCT01426399** · PHASE1 · COMPLETED · sponsor: **LG Life Sciences** · enrollment: 30 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** LC15-0444
- **DRUG:** Metformin
- **DRUG:** LC15-0444+Metformin

## Key facts

- **NCT ID:** NCT01426399
- **Lead sponsor:** LG Life Sciences
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-08
- **Primary completion:** 2011-11
- **Final completion:** 2011-12
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2011-12-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01426399

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01426399, "Pharmacokinetic/Pharmacodynamic Drug-drug Interaction of LC15-0444 and Metformin After Oral Administration in Healthy Male Subjects". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT01426399. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*